GlaxoSmithKline Pharmaceuticals P/B Ratio

Current P/B Ratio
24.26
High Valuation
Very High - Significant premium, high growth expectations or speculative

GlaxoSmithKline Pharmaceuticals P/B ratio. GlaxoSmithKline Pharmaceuticals (GLAXO) P/B ratio is 24.26 (High), book value per share ₹134.14 vs Healthcare average P/B of -0.3 — Very High - Significant premium, high growth expectations or speculative. Browse GLAXO cash flow statement for revenue, profit, balance sheet and cash flow data.

Current Valuation Metrics

P/B Ratio 24.26
Current Price ₹2713.40
Book Value/Share ₹134.14
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹2,267 Cr
Share Capital ₹169 Cr
Reserves & Surplus ₹2,098 Cr
Outstanding Shares 169,000,000
Book Value per Share ₹134.14

Valuation Signal

Signal Overvalued
Historical Avg 17.97
Historical Range 8.37 - 21.43
Percentile 100.0%

Sector Context

Sector Average -0.3
Sector Median 0.39
Sector Rank #11 of 50
Sector Percentile 22.0%

GLAXO P/B Ratio — Valuation Insights & Book Value Analysis

GlaxoSmithKline Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 24.26 (High). Read GLAXO dividend yield for the complete payout history and dividend yield track record.

  • Stock appears overvalued with PB of 24.26, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Current PB is 35.0% above historical average
  • Trading at premium to sector average PB of -0.3

GlaxoSmithKline Pharmaceuticals P/B Ratio Historical Trend

GLAXO annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see GlaxoSmithKline Pharmaceutical stock price NSE.

GLAXO Historical P/B Ratio — Book Value Per Share & Year-End Price

GlaxoSmithKline Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 20.23 ₹134.14 ₹2713.40 ₹2,267 High
2025 21.43 ₹115.44 ₹2473.60 ₹1,951 High
2024 21.4 ₹105.21 ₹2251.85 ₹1,778 High
2023 18.43 ₹103.02 ₹1898.15 ₹1,741 High
2022 8.37 ₹157.57 ₹1318.75 ₹2,663 High

GLAXO vs Healthcare Peers — P/B Ratio Comparison

GlaxoSmithKline Pharmaceuticals P/B 24.26 vs Healthcare average -0.3, median 0.39 — range -7.62–0.89.

Sector Average
-0.3
Sector Median
0.39
Lowest P/B
-7.62
Highest P/B
0.89
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Chennai Meenakshi Multis… CMMHOSP -7.62 ₹27 Low
Parmax Pharma PARMAX -6.55 ₹46 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -1.2 ₹39 Low
Krebs Biochemicals & Ind… KREBSBIO -0.75 ₹128 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.18 ₹43 Low